Noninvasive intranasal stem cells and other therapeutic cells bypass the blood-brain barrier to target the CNS to treat Parkinson's disease, stroke, neonatal ischemia, hemorrhage, multiple sclerosis, brain tumors, TBI, Alzheimer's and other CNS disorders
eliminating the need for invasive neurosurgical implantation of cells and by eliminating the need for intravenous delivery that disperses cells throughout the body resulting in an unwanted systemic exposure. This

